Page 21 - Rna Synthesis Custom Service Providers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rna synthesis custom service providers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rna Synthesis Custom Service Providers Today - Breaking & Trending Today

Sarah Boyce Sells 5,092 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) Stock

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) CEO Sarah Boyce sold 5,092 shares of the company’s stock in a transaction on Monday, January 22nd. The shares were sold at an average price of $10.13, for a total value of $51,581.96. Following the completion of the transaction, the chief executive officer now owns 44,008 shares […] ....

Sarah Boyce , Charles Schwab Investment Management Inc , Vanguard Group Inc , Wells Fargo Company , Metlife Investment Management , Needham Company , Dimensional Fund Advisors , Avidity Biosciences Inc , Avidity Biosciences , Get Free Report , Life Investment Management , Fund Advisors , Charles Schwab Investment Management , Schwab Investment Management , Avidity Biosciences Daily , Nasdaq Rna , Insider Trading , Nsider Trades ,

Avidity Biosciences, Inc. (NASDAQ:RNA) CEO Sells $51,581.96 in Stock

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) CEO Sarah Boyce sold 5,092 shares of the business’s stock in a transaction on Monday, January 22nd. The stock was sold at an average price of $10.13, for a total value of $51,581.96. Following the sale, the chief executive officer now owns 44,008 shares of the company’s […] ....

Sarah Boyce , Avidity Biosciences Inc , Needham Company , Nisa Investment Advisors , Ancora Advisors , Royal Bank , Securities Exchange Commission , Wells Fargo Company , Avidity Biosciences , Get Free Report , Exchange Commission , Investment Advisors , Avidity Biosciences Daily , Nasdaq Rna , Insider Trading , Nsider Trades ,

Insider Selling: Avidity Biosciences, Inc. (NASDAQ:RNA) Director Sells 1,859 Shares of Stock

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) Director Arthur A. Levin sold 1,859 shares of the company’s stock in a transaction dated Monday, January 22nd. The shares were sold at an average price of $10.13, for a total transaction of $18,831.67. Following the transaction, the director now directly owns 17,471 shares of the company’s […] ....

United States , Arthura Levin , Avidity Biosciences Company Profile , Group Plc , Wells Fargo Company , Needham Company , Proshare Advisors , American International Group Inc , Avidity Biosciences Inc , Us Bancorp , Securities Exchange Commission , Avidity Biosciences , Get Free Report , Director Arthur , Exchange Commission , General Group Plc , International Group , Share Advisors , Arizona State Retirement System , State Retirement System , Avidity Biosciences Daily , Nasdaq Rna , Insider Trading , Nsider Trades ,

Michael F. Maclean Sells 1,616 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) Stock

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) CFO Michael F. Maclean sold 1,616 shares of Avidity Biosciences stock in a transaction dated Monday, January 22nd. The shares were sold at an average price of $10.13, for a total value of $16,370.08. Following the completion of the transaction, the chief financial officer now directly owns […] ....

United States , Michaelf Maclean , Avidity Biosciences Company Profile , Group Plc , Wells Fargo Company , Needham Company , American International Group Inc , Proshare Advisors , Avidity Biosciences Inc , Us Bancorp , Securities Exchange Commission , Avidity Biosciences , Get Free Report , Exchange Commission , General Group Plc , International Group , Share Advisors , Arizona State Retirement System , State Retirement System , Avidity Biosciences Daily , Nasdaq Rna , Insider Trading , Nsider Trades ,